Total Voting Rights

Released: 03/07/2023 13:30:00

RNS Number : 7607EAnglo American PLC03 July 2023

Anglo American plc (the "Company")

Registered office: 17 Charterhouse Street, London EC1N 6RA

Registered number: 3564138 (incorporated in England and Wales)

Legal Entity Identifier: 549300S9XF92D1X8ME43

Total voting rights

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.

As at 6pm on 30 June 2023, the issued share capital of the Company was 1,337,577,913 ordinary shares of US$0.54945 each. No shares are held in Treasury, therefore the total number of voting rights in the Company is 1,337,577,9131.

This information may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Chandrika Kher

Anglo American plc

3 July 2023

Note 1. Of these 112,300,129 shares are held by Epoch Investment Holdings (RF) Proprietary Limited, Epoch Two Investment Holdings (RF) Proprietary Limited and Tarl Investment Holdings (RF) Proprietary Limited, the independent companies which purchased shares as part of the Company's 2006 share buyback programme. These independent companies have waived their right to vote all the shares they hold or will hold in the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDTVRFZGGNGFNGFZM